These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 10565854)

  • 1. O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity.
    Alvino E; Pepponi R; Pagani E; Lacal PM; Nunziata C; Bonmassar E; D'Atri S
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1292-300. PubMed ID: 10565854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.
    Pagani E; Pepponi R; Fuggetta MP; Prete SP; Turriziani M; Bonmassar L; Lacal PM; Falcinelli S; Passarelli F; Guadagni F; Alvino E; D'Atri S
    J Chemother; 2003 Apr; 15(2):173-83. PubMed ID: 12797396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
    Lacal PM; D'Atri S; Orlando L; Bonmassar E; Graziani G
    J Pharmacol Exp Ther; 1996 Oct; 279(1):416-22. PubMed ID: 8859021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.
    Tentori L; Graziani G; Gilberti S; Lacal PM; Bonmassar E; D'Atri S
    Leukemia; 1995 Nov; 9(11):1888-95. PubMed ID: 7475280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase.
    Tentori L; Lacal PM; Benincasa E; Franco D; Faraoni I; Bonmassar E; Graziani G
    J Pharmacol Exp Ther; 1998 May; 285(2):884-93. PubMed ID: 9580640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia.
    Graziani G; Faraoni I; Grohmann U; Bianchi R; Binaglia L; Margison GP; Watson AJ; Orlando L; Bonmassar E; D'Atri S
    Cancer Res; 1995 Dec; 55(24):6231-6. PubMed ID: 8521419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea, and cisplatin.
    Pepponi R; Marra G; Fuggetta MP; Falcinelli S; Pagani E; Bonmassar E; Jiricny J; D'Atri S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):661-8. PubMed ID: 12538819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.
    Turriziani M; Caporaso P; Bonmassar L; Buccisano F; Amadori S; Venditti A; Cantonetti M; D'Atri S; Bonmassar E
    Pharmacol Res; 2006 Apr; 53(4):317-23. PubMed ID: 16412662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.
    Caporali S; Alvino E; Starace G; Ciomei M; Brasca MG; Levati L; Garbin A; Castiglia D; Covaciu C; Bonmassar E; D'Atri S
    Pharmacol Res; 2010 May; 61(5):437-48. PubMed ID: 20026273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
    Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
    Reese JS; Davis BM; Liu L; Gerson SL
    Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.
    Kanzawa T; Germano IM; Kondo Y; Ito H; Kyo S; Kondo S
    Br J Cancer; 2003 Sep; 89(5):922-9. PubMed ID: 12942127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base excision repair as a therapeutic target in colon cancer.
    Liu L; Nakatsuru Y; Gerson SL
    Clin Cancer Res; 2002 Sep; 8(9):2985-91. PubMed ID: 12231545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazene compounds: mechanism of action and related DNA repair systems.
    Marchesi F; Turriziani M; Tortorelli G; Avvisati G; Torino F; De Vecchis L
    Pharmacol Res; 2007 Oct; 56(4):275-87. PubMed ID: 17897837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine.
    Toft NJ; Sansom OJ; Brookes RA; Arends MJ; Wood M; Margison GP; Winton DJ; Clarke AR
    Carcinogenesis; 2000 Apr; 21(4):593-8. PubMed ID: 10753191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
    Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
    J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
    Liu L; Markowitz S; Gerson SL
    Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of methyltriazene prodrugs simultaneously releasing DNA-methylating agents and the antiresistance drug O(6)-benzylguanine.
    Wanner MJ; Koch M; Koomen GJ
    J Med Chem; 2004 Dec; 47(27):6875-83. PubMed ID: 15615536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.